{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:37:55Z","timestamp":1762101475207},"reference-count":56,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.prp.2013.09.010","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T21:01:32Z","timestamp":1380920492000},"page":"5-9","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Chronic effects of clozapine administration on insulin resistance in rats: Evidence for adverse metabolic effects"],"prefix":"10.1016","volume":"210","author":[{"given":"Mohamed M.","family":"El-Seweidy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermin Abdel Hamid","family":"Sadik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa M.","family":"Malek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawia S.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prp.2013.09.010_bib0005","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2165\/00003495-199753060-00002","article-title":"Drug treatment of schizophrenia in the 1990. Achievements and future possibilities in optimising outcomes","volume":"53","author":"Fleischhacker","year":"1997","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.prp.2013.09.010_bib0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1742-1241.1996.tb09562.x","article-title":"Advances in the treatment of schizophrenia","volume":"50","author":"Kuperberg","year":"1996","journal-title":"Br. J. Clin. Pract."},{"issue":"2","key":"10.1016\/j.prp.2013.09.010_bib0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/schbul\/19.2.303","article-title":"Tardive dyskinesia","volume":"19","author":"Jeste","year":"1993","journal-title":"Schizophr. Bull."},{"issue":"11","key":"10.1016\/j.prp.2013.09.010_bib0020","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.prp.2013.09.010_bib0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/1097-0134(20010301)42:4<531::AID-PROT110>3.0.CO;2-9","article-title":"Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport","volume":"42","author":"Dwyer","year":"2001","journal-title":"Proteins"},{"key":"10.1016\/j.prp.2013.09.010_bib0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0028-1094313","article-title":"Das klinische Wirkungsbild von Clozapin (Untersuchungen mit dem AMP-System)","volume":"13","author":"Angst","year":"1971","journal-title":"Pharmacopsychiatrie"},{"key":"10.1016\/j.prp.2013.09.010_bib0035","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","article-title":"Clozapine \u2013 a novel antipsychotic agent","volume":"324","author":"Baldessarini","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.prp.2013.09.010_bib0040","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.prp.2013.09.010_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","article-title":"Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes","volume":"51","author":"McGarry","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.prp.2013.09.010_bib0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1176\/ajp.149.1.68","article-title":"Clozapine-induced weight gain: prevalence and clinical relevance","volume":"149","author":"Leadbetter","year":"1992","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.prp.2013.09.010_bib0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0022-3999(02)00471-3","article-title":"Abnormalities in glucose regulation associated with mental illness and treatment","volume":"53","author":"Haupt","year":"2002","journal-title":"J. Psychosom. Res."},{"issue":"1","key":"10.1016\/j.prp.2013.09.010_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","article-title":"Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis","volume":"62","author":"Henderson","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.prp.2013.09.010_bib0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"issue":"1","key":"10.1016\/j.prp.2013.09.010_bib0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/schbul\/sbq053","article-title":"Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids: impairing metabolic flexibility in rodents","volume":"38","author":"Albaugh","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.prp.2013.09.010_bib0075","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/aje\/kwj289","article-title":"Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia","volume":"164","author":"Lambert","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.prp.2013.09.010_bib0080","series-title":"Molecular Cell Biology","first-page":"658","author":"Lodiah","year":"2007"},{"key":"10.1016\/j.prp.2013.09.010_bib0085","doi-asserted-by":"crossref","first-page":"31268","DOI":"10.1074\/jbc.M603258200","article-title":"Transcriptional regulation of G-6-phosphatase Gene by cAmp\/vasoactive intestinal peptide in the intestine. Role of HNF4\u03b1,cREM, HNF1\u03b1 and c\/EBP\u03b1","volume":"281","author":"Amandine","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1-3","key":"10.1016\/j.prp.2013.09.010_bib0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","article-title":"Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model","volume":"108","author":"Chintoh","year":"2009","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.prp.2013.09.010_bib0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prp.2013.09.010_bib0100","first-page":"246","article-title":"Determination of blood glucose using 4-aminophenazone","volume":"2","author":"Trinder","year":"1959","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2013.09.010_bib0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diab.27.9.931","article-title":"Microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus","volume":"27","author":"Abraham","year":"1978","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.prp.2013.09.010_bib0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1210\/endo-110-1-23","article-title":"Stress-induced inhibition of the plasma corticosterone response to a subsequent stress in rats: a nonadrenocorticotropin-mediated mechanism","volume":"110","author":"De Souza","year":"1982","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.prp.2013.09.010_bib0115","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0031-9384(87)90282-4","article-title":"Effects of chronic stress on plasma corticosterone: ACTH and prolactin","volume":"40","author":"Kant","year":"1987","journal-title":"Physiol. Behav."},{"issue":"7","key":"10.1016\/j.prp.2013.09.010_bib0120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.prp.2013.09.010_bib0125","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000046098","article-title":"HOMA index to assess insulin resistance in renal failure patients","volume":"89","author":"Shoji","year":"2001","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.prp.2013.09.010_bib0130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1042\/bj0560646","article-title":"A colorimetric micro-method for the determination of glycogen in tissues","volume":"56","author":"Kemp","year":"1954","journal-title":"Biochem. J."},{"key":"10.1016\/j.prp.2013.09.010_bib0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0076-6879(66)08094-7","volume":"8","author":"Hers","year":"1966","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.prp.2013.09.010_bib0140","first-page":"156","article-title":"Single step method of RNA isolation by acid guanidinium thiocyanate\u2013phenolchloroform method","volume":"162","author":"Chomkczynski","year":"1987","journal-title":"Anal. Biochem."},{"issue":"Suppl 27","key":"10.1016\/j.prp.2013.09.010_bib0145","first-page":"15","article-title":"Hyperglycemia and antipsychotic medications","volume":"62","author":"Haupt","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.prp.2013.09.010_bib0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.59.4.337","article-title":"Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia","volume":"59","author":"Newcomer","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.prp.2013.09.010_bib0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000101694","article-title":"Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus","volume":"85","author":"Piroli","year":"2007","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.prp.2013.09.010_bib0160","first-page":"414","article-title":"Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects","volume":"174","author":"Cohrs","year":"2004","journal-title":"Psychopharmacology(Berl.)"},{"issue":"1","key":"10.1016\/j.prp.2013.09.010_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00213-005-0279-x","article-title":"The atypical antipsychotics olanzapine and quetiapine: but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects","volume":"185","author":"Cohrs","year":"2006","journal-title":"Psychopharmacology(Berl.)"},{"issue":"1","key":"10.1016\/j.prp.2013.09.010_bib0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.prp.2013.09.010_bib0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.prp.2013.09.010_bib0180","first-page":"85","article-title":"Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs","volume":"286","author":"Egan","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.prp.2013.09.010_bib0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.bjp.0700921","article-title":".Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes","volume":"120","author":"Hirst","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2013.09.010_bib0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/diabetes.53.1.14","article-title":"Portal serotonin infusion and glucose disposal in conscious dogs","volume":"53","author":"Moore","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2013.09.010_bib0195","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes (Consensus Statement)","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"issue":"36","key":"10.1016\/j.prp.2013.09.010_bib0200","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.0803522105","article-title":"Antagonism of dopamine D2 receptor\/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics","volume":"105","author":"Masri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.prp.2013.09.010_bib0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1471-4159.2001.00233.x","article-title":"Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation","volume":"77","author":"Wilson","year":"2001","journal-title":"J. Neurochem."},{"issue":"Pt 1","key":"10.1016\/j.prp.2013.09.010_bib0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/bj3360019","article-title":"Specific features of glycogen metabolism in the liver","volume":"336","author":"Bollen","year":"1998","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.prp.2013.09.010_bib0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0968-0004(92)90504-3","article-title":"Phosphorylase: a biological transducer","volume":"17","author":"Browner","year":"1992","journal-title":"Trends Biochem. Sci."},{"issue":"6","key":"10.1016\/j.prp.2013.09.010_bib0220","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1096\/fasebj.6.6.1544539","article-title":"Glycogen phosphorylase: control by phosphorylation and allosteric effectors","volume":"6","author":"Johnson","year":"1992","journal-title":"FASEB J."},{"issue":"26","key":"10.1016\/j.prp.2013.09.010_bib0225","doi-asserted-by":"crossref","first-page":"23858","DOI":"10.1074\/jbc.M101454200","article-title":"Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis","volume":"276","author":"Aiston","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2013.09.010_bib0230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/0264-6021:3620513","article-title":"The glucose 6 phosphatase system","volume":"362","author":"Van Schafinger","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.prp.2013.09.010_bib0235","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2337\/diab.45.7.891","article-title":"G-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats","volume":"45","author":"Mithieux","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2013.09.010_bib0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00714331","article-title":"Differential time course of liver and kidney G-6-Pase activity during long term fasting in rat correlates with differential time course of mRNA level","volume":"155","author":"Minassian","year":"1996","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.prp.2013.09.010_bib0245","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2337\/diabetes.50.4.740","article-title":"Rat small intestine is an insulin sensitive gluconeogenic organ","volume":"50","author":"Croset","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2013.09.010_bib0250","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1172\/JCI106016","article-title":"Liver and kidney metabolism during prolonged starvation","volume":"48","author":"Owen","year":"1969","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.prp.2013.09.010_bib0255","doi-asserted-by":"crossref","first-page":"E370","DOI":"10.1152\/ajpendo.00299.2003","article-title":"Zitoun, C. induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes","volume":"286","author":"Mithieux","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2013.09.010_bib0260","article-title":"Role of glucokinase and G-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin","volume":"268","author":"Brazilai","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2013.09.010_bib0265","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0016-5085(99)70559-7","article-title":"The G-6-pase gene is expressed in human, rat small intestine, regulation of expression in fasted and diabetic rats","volume":"117","author":"Rajas","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2013.09.010_bib0270","doi-asserted-by":"crossref","first-page":"31615","DOI":"10.1074\/jbc.273.47.31615","article-title":"Perturbation of fuel homeostasis caused by overexpression of the G-6-phosphatase catalytic subunit in liver of normal rats","volume":"273","author":"Trinh","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.prp.2013.09.010_bib0275","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2337\/diabetes.47.6.882","article-title":"Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes","volume":"47","author":"Chatelain","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2013.09.010_bib0280","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/diabetes.49.6.969","article-title":"G-6-pase flux in vitro is increased in type 2 diabetes","volume":"49","author":"Clore","year":"2000","journal-title":"Diabetes"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033813003051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033813003051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T01:55:07Z","timestamp":1688522107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033813003051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0344033813003051"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2013.09.010","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic effects of clozapine administration on insulin resistance in rats: Evidence for adverse metabolic effects","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2013.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}